Suppr超能文献

增强先前腹部影像学正常的患者的肾脏肿瘤:对肾细胞癌自然史的进一步了解。

Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma.

机构信息

Department of Surgery, University of Kentucky, Lexington, Kentucky 40536, USA.

出版信息

J Urol. 2012 Oct;188(4):1089-93. doi: 10.1016/j.juro.2012.06.019. Epub 2012 Aug 15.

Abstract

PURPOSE

Patients undergoing serial cross-sectional abdominal imaging to evaluate abdominal symptomatology may have a renal tumor develop during followup of an unrelated disease process. Evaluation of such patients provides an opportunity to further define the radiographic inception, natural history and growth patterns of renal tumors.

MATERIALS AND METHODS

Renal tumor databases from 2 institutions were reviewed for patients in whom an enhancing renal tumor developed despite a prior normal cross-sectional radiographic examination of the kidneys. Variables evaluated included age, gender, tumor size at presentation, calculated tumor growth rate from negative scan to radiographic presentation and pathology in patients undergoing definitive treatment.

RESULTS

We identified 36 patients with an average age of 65 years (range 44 to 82). Mean tumor size on presentation was 2.3 cm (range 1.0 to 5.0). The presumed absolute growth rate based on the timing of the initial negative imaging study and tumor diameter at presentation was significantly greater than the observed absolute growth rate after tumor detection (0.71 vs 0.039 cm per year, p = 0.028). No difference was noted between presumed and observed tumor growth based on absolute change in tumor volume (1.44 vs 5.37 cm(3) per year, p = 0.203). Presumed relative growth rates based on tumor diameter (665% vs 23% per year) and volume (1,397% vs 169% per year) were significantly greater than observed relative growth rates (p = 0.005 and p = 0.013, respectively).

CONCLUSIONS

The presumed growth rate of the tumors was significantly greater than the observed growth rate, suggesting that tumor growth rates do not follow a linear pattern throughout their development and progression.

摘要

目的

在随访无关疾病过程中,接受连续横断面腹部成像以评估腹部症状的患者可能会出现肾肿瘤。对这些患者的评估提供了进一步确定肾肿瘤的放射学起始,自然史和生长模式的机会。

材料和方法

对 2 个机构的肾肿瘤数据库进行了回顾,以寻找尽管先前对肾脏进行了正常的横断面影像学检查,但仍出现增强性肾肿瘤的患者。评估的变量包括年龄,性别,肿瘤出现时的大小,从阴性扫描到放射学表现的肿瘤生长速率的计算以及接受确定性治疗的患者的病理学。

结果

我们确定了 36 名平均年龄为 65 岁(范围为 44 至 82 岁)的患者。出现时的平均肿瘤大小为 2.3 厘米(范围为 1.0 至 5.0)。根据最初的阴性影像学研究的时间和出现时肿瘤直径,推测的绝对生长率明显大于肿瘤检测后观察到的绝对生长率(0.71 与 0.039 cm/年,p = 0.028)。根据肿瘤体积的绝对变化,肿瘤的推测和观察到的生长没有差异(每年 1.44 与 5.37 cm(3),p = 0.203)。基于肿瘤直径的推测相对生长率(每年 665%和 23%)和体积(每年 1397%和 169%)均明显大于观察到的相对生长率(p = 0.005 和 p = 0.013)。

结论

肿瘤的推测生长率明显大于观察到的生长率,这表明肿瘤生长率在其发展和进展过程中并不遵循线性模式。

相似文献

2
Predicting growth of solid renal masses under active surveillance.
Urol Oncol. 2008 Sep-Oct;26(5):555-9. doi: 10.1016/j.urolonc.2008.03.010.
3
Enhancing renal masses with zero net growth during active surveillance.
J Urol. 2007 Mar;177(3):849-53; discussion 853-4. doi: 10.1016/j.juro.2006.10.073.
4
Comparison of radiographic and pathologic sizes of renal tumors.
Int Braz J Urol. 2013 Mar-Apr;39(2):189-94. doi: 10.1590/S1677-5538.IBJU.2013.02.06.
5
The natural history of incidentally detected small renal masses.
Cancer. 2004 Feb 15;100(4):738-45. doi: 10.1002/cncr.20025.
6
Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance.
J Urol. 2014 Sep;192(3):659-64. doi: 10.1016/j.juro.2014.03.038. Epub 2014 Mar 15.
7
Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
Eur Urol. 2011 May;59(5):863-7. doi: 10.1016/j.eururo.2011.02.023. Epub 2011 Feb 22.
8
Natural history of renal cell carcinoma: An immunohistochemical analysis of growth rate in patients with delayed treatment.
J Formos Med Assoc. 2016 Jun;115(6):463-9. doi: 10.1016/j.jfma.2015.05.003. Epub 2015 Jun 6.
9
Distribution of renal tumor growth rates determined by using serial volumetric CT measurements.
Radiology. 2009 Jan;250(1):137-44. doi: 10.1148/radiol.2501071712.

引用本文的文献

1
Renal tumor growth rate in patients with previously normal CT scan: Analysis of the initial stage of growth.
Turk J Urol. 2021 Jan;47(1):9-13. doi: 10.5152/tud.2020.20201. Epub 2020 Oct 9.
2
Mathematical Models for Tumor Growth and the Reduction of Overtreatment.
J Neurol Surg B Skull Base. 2019 Feb;80(1):72-78. doi: 10.1055/s-0038-1667148. Epub 2018 Jul 23.
3
Renal functional outcomes after surgery for renal cortical tumors.
J Kidney Cancer VHL. 2015 Apr 4;2(2):45-54. doi: 10.15586/jkcvhl.2015.26. eCollection 2015.

本文引用的文献

1
Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.
Cancer. 2012 Feb 15;118(4):997-1006. doi: 10.1002/cncr.26369. Epub 2011 Jul 15.
2
Basic research in kidney cancer.
Eur Urol. 2011 Oct;60(4):622-33. doi: 10.1016/j.eururo.2011.06.048. Epub 2011 Jul 5.
3
Active surveillance of small renal masses: progression patterns of early stage kidney cancer.
Eur Urol. 2011 Jul;60(1):39-44. doi: 10.1016/j.eururo.2011.03.030. Epub 2011 Apr 1.
4
Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years.
Urology. 2011 Apr;77(4):787-91. doi: 10.1016/j.urology.2010.09.031. Epub 2010 Dec 16.
5
Signaling pathways in renal cell carcinoma.
Cancer Biol Ther. 2010 Oct 1;10(7):658-64. doi: 10.4161/cbt.10.7.13247.
6
Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms.
Urology. 2010 Sep;76(3):620-3. doi: 10.1016/j.urology.2010.04.021.
7
Active surveillance for renal cortical neoplasms.
J Urol. 2010 May;183(5):1698-702. doi: 10.1016/j.juro.2010.01.024. Epub 2010 Mar 17.
9
Predicting growth of solid renal masses under active surveillance.
Urol Oncol. 2008 Sep-Oct;26(5):555-9. doi: 10.1016/j.urolonc.2008.03.010.
10
The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Eur Urol. 2008 Oct;54(4):855-63. doi: 10.1016/j.eururo.2008.04.079. Epub 2008 May 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验